We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Mercury Systems
MRCY
$6.2B
| $16.9M | ﹤0.01% |
231,784
-119,346
| -34% | -$10.4M |
|
|
SARO
1227
StandardAero Inc
SARO
$9.54B
| $16.9M | ﹤0.01% |
652,917
+17,723
| +3% | +$529K |
|
1228
Houlihan Lokey
HLI
$9.68B
| $16.8M | ﹤0.01% |
117,197
-1,623
| -1% | -$267K |
|
1229
Essent Group
ESNT
$6.06B
| $16.8M | ﹤0.01% |
287,292
-2,253
| -0.8% | -$138K |
|
1230
Vita Coco
COCO
$3.77B
| $16.7M | ﹤0.01% |
349,529
+8,999
| +3% | +$491K |
|
1231
Enphase Energy
ENPH
$4.84B
| $16.7M | ﹤0.01% |
441,444
-33,039
| -7% | -$1.37M |
|
1232
Pathward Financial
CASH
$1.81B
| $16.7M | ﹤0.01% |
186,889
-31,617
| -14% | -$2.75M |
|
|
NESR
1233
National Energy Services Reunited Corp
NESR
$2.79B
| $16.7M | ﹤0.01% |
776,390
+627,626
| +422% | +$13.1M |
|
1234
Otter Tail
OTTR
$3.88B
| $16.6M | ﹤0.01% |
189,228
+37,206
| +24% | +$3.22M |
|
1235
Enact Holdings
ACT
$6.53B
| $16.4M | ﹤0.01% |
401,042
-58,694
| -13% | -$2.4M |
|
1236
Hanover Insurance
THG
$7.63B
| $16.3M | ﹤0.01% |
94,208
+43,706
| +87% | +$7.6M |
|
1237
Zymeworks
ZYME
$1.68B
| $16.3M | ﹤0.01% |
651,662
+3,336
| +0.5% | +$78.9K |
|
1238
Hamilton Lane
HLNE
$3.63B
| $16.3M | ﹤0.01% |
164,106
-11,912
| -7% | -$1.46M |
|
|
CVSA
1239
Covista Inc
CVSA
$3.94B
| $16.3M | ﹤0.01% |
141,473
+55,867
| +65% | +$5.97M |
|
1240
SI-BONE Inc
SIBN
$737M
| $16.2M | ﹤0.01% |
1,285,511
-136,435
| -10% | -$2.13M |
|
1241
Cognex
CGNX
$10.3B
| $16.1M | ﹤0.01% |
329,593
+23,106
| +8% | +$1.08M |
|
1242
AeroVironment
AVAV
$7.57B
| $16.1M | ﹤0.01% |
87,920
-77,504
| -47% | -$20.4M |
|
1243
Enova International
ENVA
$5.91B
| $16.1M | ﹤0.01% |
118,194
+41,329
| +54% | +$6.15M |
|
1244
Vera Therapeutics
VERA
$2.54B
| $16M | ﹤0.01% |
398,602
+171,521
| +76% | +$7.39M |
|
1245
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $16M | ﹤0.01% |
24,951
-16,845
| -40% | -$11.5M |
|
1246
Center Bancorp
CNOB
$1.63B
| $16M | ﹤0.01% |
598,692
+2,673
| +0.4% | +$71.9K |
|
1247
CarGurus
CARG
$3.01B
| $16M | ﹤0.01% |
470,321
+2,500
| +0.5% | +$81.8K |
|
1248
SharkNinja
SN
$21B
| $16M | ﹤0.01% |
151,075
+4,521
| +3% | +$529K |
|
1249
Prestige Consumer Healthcare
PBH
$2.35B
| $16M | ﹤0.01% |
269,392
-1,987
| -0.7% | -$129K |
|
1250
Fulton Financial
FULT
$4.7B
| $16M | ﹤0.01% |
784,641
-161,723
| -17% | -$3.33M |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.